U.S. Court of Appeals Upholds Validity of Lilly's Evista Patents (LLY)

Eli Lilly and Company LLY today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed a prior ruling by the U.S. District Court for the Southern District of Indiana that the company's method-of-use patents for Evista are valid. These patents provide protection for Evista in the U.S. through March of 2014. Click here to get today's best trading ideas.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: News
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!